Snowball Research
Snowball Research
Sub $5B US stocks research hub
⌘K
Subscribe Sign in
paid-only post activistprofile

Lee Elvin Sanghwan

by Snowball Research Team

I. Basics

Lee Elvin Sanghwan is a U.S.‐based activist investor noted for accumulating just over 6% of Salarius Pharmaceuticals in late 2023 and disclosing it via a Schedule 13D. Based out of Teaneck, NJ, he appears to hold a professional background in pharma quality/regulatory roles

II. Letters & Presentations

Nil

III. Significant companies
Below is a list of company engagements where the filer has filed a Schedule 13D and/or engaged in a proxy campaign. As the filer does not file a Form 13F, current ownership information is not available.
This post is for paying subscribers only

Subscribe to continue reading


More like this

Ephraim G Fields

I. Basics Ephraim G. Fields is an activist investor in New York, known for founding Echo Lake Capital and triggering

Farallon Capital Partners

I. Basics Farallon Capital Partners, L.P. (also known as Farallon Capital Management) is a leading multi-strategy hedge fund headquartered

Hill Path Capital

I. Basics Hill Path Capital is a private investment firm founded in 2014 by Scott Ross, who serves as Managing

Voce Capital Management

I. Basics Voce Capital Management LLC is a 100% employee-owned hedge fund manager based in San Francisco, managing a group

Star Equity Fund

I. Basics Star Equity Fund, LP is an Old Greenwich, Connecticut–based activist investment firm focusing on undervalued micro- and

Radoff Bradley Louis

I. Basics Mr. Radoff is a proven investor and seasoned public company director with significant experience in the areas of